This record-setting year accelerates the Taco Bell Foundation's mission to remove barriers to education and open doors for the next generation of leaders, providing funds to nearly 500 nonprofit organizations nationwide. Today, the Taco Bell Foundationannounced it is awarding a record-breaking $28 million in Community Grantsto nearly 500 nonprofit organizations across the U.S. – marking […]

Employee relations software leader launches AI Hotline, expands next-gen analytics, announces Workday Help partnership, launches new AI capabilities and earns 41 G2 awards HR Acuity, the category leader in HR case management and employee relations software, today announced a strong first half of 2025 marked by product innovation, strategic partnerships and growing industry recognition. https://mma.prnewswire.com/media/1945165/HR_Acuity_logo.jpg

TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that the U.S. Food and Drug Administration (FDA) has granted conditional approval of its Investigational Device Exemption (IDE), allowing the company to proceed with the initiation of its

DICK'S Sporting Goods, Inc. (“DICK'S”) (NYSE: DKS), a leading U.S. based full-line omni-channel sporting goods retailer, today announced the extension of the Expiration Date (as defined below) in connection with the previously announced offer to eligible holders to exchange (the “Exchange Offer”) any and all of Foot Locker, Inc.'s (“Foot Locker”) 4.000% Senior Notes due

Shilpa Medicare Serves as Lead Investor, Positioning Alveolus Bio for Phase 2 Clinical Trials and First-in-Human Studies Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingham, AL, has announced a strategic financing round led by Shilpa Medicare Limited (BSE: 524742) (NSE: SHILPAMED), a prominent

Shilpa Medicare Serves as Lead Investor, Positioning Alveolus Bio for Phase 2 Clinical Trials and First-in-Human Studies Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingham, AL, has announced a strategic financing round led by Shilpa Medicare Limited (BSE: 524742) (NSE: SHILPAMED), a prominent

— Startup eyesKosdaq listing, digital platform rollout to fuel overseas growth This is an article published in The Korea Herald: Fescaro(https://www.fescaro.com/en/), a Korean startup specializing in auto security, has defied the traditions of the original equipment manufacturer-heavy industry and is now looking to expand its all-around anti-hacking capabilities on the global stage. “A normal auto

— Indicative Net Asset Value was approximately $3.3 billion as of June 30, 2025, an increase of $252 million compared to March 31, 2025 — Q2 2025 net loss attributable to IEP was $165 million, compared to a loss of $331 million in Q2 2024 — Q2 2025 Adjusted EBITDA loss attributable to IEP was

Your Majesty, part of Infinum, unveils a new digital platform designed to elevate a leading climate tech innovator's mission and drive momentum in Direct Air Capture. Infinum'saward-winning digital design agency Your Majesty has launched a new website for a Dutch climate tech scale-up pioneering decentralized carbon capture, originally spun out of the European Space Agency.

— Used with thecobas®5800, 6800 and 8800 systems, cobas Respiratory 4-flex simultaneously detects and differentiates the four most common respiratory viruses, helping to ensure confidence in diagnosis. — The newcobas Respiratory 4-flex offers an innovative syndromic PCR testing solution, providing labs flexibility in customizing their menu panel. — The customized panel test includes a “digital